← Back

Phenobarbital

Antidotes and other Substances used In Poisonings
Injection · Tablet200mg · 15 mg · 30 mg · 60 mg
Phenobarbital is listed in Nepal's National List of Essential Medicines (NLEM, Sixth Revision 2021) under Antidotes and other Substances used In Poisonings. According to its FDA label, it is Anticonvulsant- For the treatment of generalized and partial seizures.
Generic namephenobarbital
Therapeutic classAntidotes and other Substances used In Poisonings > 4.2 Specific (complementary list)
Form & strength (NLEM)Injection: 200mg (sodium)/ ml; Tablet: 15 mg, 30 mg, 60 mg
Source / स्रोतNational List of Essential Medicines Nepal (2021); NepalDoc medicine catalog

What it's for

Anticonvulsant- For the treatment of generalized and partial seizures.

From the U.S. FDA-approved label for Phenobarbital. Full label: DailyMed.

Anticonvulsant- For the treatment of generalized and partial seizures.

From the U.S. FDA-approved label for Phenobarbital. Full label: DailyMed.

The dose of phenobarbital must be individualized with full knowledge of it particular characteristics. Factors of consideration are the patients age, weight, and condition. Sedation For sedation, the drug may be administered in single doses of 30 to 120 mg repeated at intervals; frequency will be determined by the patient's response.

Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.

Phenobarbital is contraindicated in patients who are hypersensitive to barbiturates, in patients with a history of manifest or latent porphyria, and in patients with marked impairment of liver function or respiratory disease in which dyspnea or obstruction is evident.

Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.

Habit Forming Phenobarbital may be habit forming. Tolerance and psychological and physical dependence may occur with continued use ( see DRUG ABUSE AND DEPENDENCE and Pharmacokinetics under CLINICAL PHARMACOLOGY). Patients who have psychologic dependence on barbiturates may increase the dosage or decrease the dosage interval without consulting a physician and may subsequently develop a physical dependence on barbiturates.

Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.

The following adverse reactions have been reported: CNS Depression - Residual sedation or "hangover", drowsiness, lethargy, and vertigo. Emotional disturbances and phobias may be accentuated. In some persons, barbiturates such as phenobarbital repeatedly produce excitement rather than depression, and the patient may appear to be inebriated. Irritability and hyperactivity can occur in children.

Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.

Shake well before use. Keep tightly closed. Store at 20° - 25°C (68° - 77°F).

Storage information from the U.S. FDA-approved label.

Search medicines in the app / एपमा औषधि खोज्नुहोस् Find a pharmacy / फार्मेसी खोज्नुहोस्
+ Safety information

This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.

NepalDoc — Nepal's Healthcare Super-App (Beta) / नेपालको स्वास्थ्य सुपर-एप (बेटा).
Medicine information only — not medical advice. Confirm with a pharmacist or doctor.